Umbhali: William Ramirez
Umhla Wokudalwa: 19 Eyomsintsi 2021
Hlaziya Umhla: 16 Eyenkanga 2024
Anonim
Neurofibromatosis Types 1 and 2
Ividiyo: Neurofibromatosis Types 1 and 2

I-Neurofibromatosis 2 (NF2) sisifo apho amathumba enza imithambo-luvo yengqondo kunye nomqolo (inkqubo ye-nervous system). Iyadluliselwa (ifunyenwe njengelifa) kwiintsapho.

Nangona inegama elifanayo kwi-neurofibromatosis yohlobo 1, yimeko eyahlukileyo neyahlukileyo.

I-NF2 ibangelwa kukutshintsha kohlobo lwe-NF2. I-NF2 inokugqithiswa ezantsi kwiintsapho kwipateni ephezulu ye-autosomal. Oku kuthetha ukuba ukuba omnye umzali une-NF2, nawuphi na umntwana walo mzali unethuba lama-50% lokuzuza njengelifa imeko leyo. Ezinye iimeko zeNF2 zenzeka xa uhlobo luguquka lodwa. Nje ukuba umntu aphathe utshintsho lwemfuza, abantwana babo banethuba lokufumana ilifa njenge-50%.

Eyona nto iphambili emngciphekweni wokuba nembali yosapho kwimeko.

Iimpawu zeNF2 zibandakanya:

  • Iingxaki zokulinganisela
  • I-cataract esemncinci
  • Utshintsho kumbono
  • Iimpawu ezinemibala yekofu kulusu (i-café-au-lait), azixhaphakanga
  • Intloko ebuhlungu
  • Ukuphulukana nokuva
  • Ukukhala kunye nengxolo ezindlebeni
  • Ubuthathaka bobuso

Iimpawu zeNF2 zibandakanya:


  • Ubunzima kunye nezidumbu zomqolo
  • Izidumba ezinxulumene nokuva (i-acoustic)
  • Amathumba esikhumba

Uvavanyo lubandakanya:

  • Uvavanyo lomzimba
  • Imbali yezonyango
  • IMRI
  • Ukuskena i-CT
  • Uvavanyo lwemfuzo

Amathumba acoustic anokujongwa, okanye anyangwe ngotyando okanye ngemitha.

Abantu abanale ngxaki banokuzuza kwiingcebiso ngemfuzo.

Abantu abane-NF2 kufuneka bavavanywe rhoqo ngezi mvavanyo:

  • I-MRI yengqondo kunye nentambo yomqolo
  • Ukuva nokuvavanywa kwentetho
  • Uvavanyo lwamehlo

Ezi zixhobo zilandelayo zinokubonelela ngolwazi oluthe kratya kwiNF2:

  • Isiseko seTumor yaBantwana- www.ctf.org
  • Inethiwekhi yeNeurofibromatosis- www.nfnetwork.org

NF2; I-Bilateral acoustic neurofibromatosis; Iingqungquthela ze-vestibular schwannomas; I-neurofibromatosis esembindini

  • Inkqubo ye-nervous central kunye ne-peripheral system

Sahin M, Ullrich N, Srivastava S, Pinto A.Ii-syndromes zeNeurocutaneous syndromes. Ku: Kliegman RM, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, ii-eds. Incwadi kaNelson yeNcwadi yePediatrics. Umhla wama-21. IPhiladelphia, PA: Elsevier; 2020: isahluko 614.


Isilayidi WH. Neurofibromatosis 2. Ku: Brackmann DE, Shelton C, Arriaga MA, eds. Utyando lweOtologic. Ngomhla we-4. IPhiladelphia, PA: Elsevier; Ngo-2016: isahluko 57.

UVarma R, uWill SD. Neurology. Ku: Zitelli BJ, McIntire SC, Nowalk AJ, ii-eds. UZitelli no-Davis ’Atlas of Pediatric Physical Diagnosis. Umhla wesi-7. IPhiladelphia, PA: Elsevier; I-2018: isahluko 16.

Kucetyiswa

I-Amiodarone, iThebhulethi yomlomo

I-Amiodarone, iThebhulethi yomlomo

Ithebhulethi yomlomo we-Amiodarone iyafumaneka njengechiza elenziwa lafana nelo kunye negama lophawu. Igama lebrand: Pacerone.I-Amiodarone ikwafumaneka njenge i ombululo enaliti. Ungaqala ngecwecwe lo...
Yonke into obufuna ukuyazi malunga ne-SGLT2 Inhibitors

Yonke into obufuna ukuyazi malunga ne-SGLT2 Inhibitors

U hwankatheloI- GLT2 inhibitor ludidi lwamayeza a etyenzi elwa ukunyanga i ifo e wekile e i-2. Zikwabizwa ngokuba yiprotein zothutho lwe odium-gluco e 2 inhibitor okanye ii-gliflozin . I- GLT2 inhibi...